Skip to Content

MYLAN 217 250 (Tolazamide 250 mg)

Pill with imprint MYLAN 217 250 is White, Round and has been identified as Tolazamide 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tolazamide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Tolazamide 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for MYLAN 217 250

Tolazamide 250 mg MYLAN 217 250
Tolazamide 250 mg MYLAN 217 250 Front
Tolazamide 250 mg MYLAN 217 250 Back
Tolazamide 250 mg MYLAN 217 250


MYLAN 217 250
250 mg
10.00 mm
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0556 Amerisource Health Services

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.